Sechs Fälle von Pityriasis rosea nach SARS-CoV-2-Impfung mit BNT162b2
J Dtsch Dermatol Ges
.
2022 Aug;20(8):1123-1125.
doi: 10.1111/ddg.14784_g.
Authors
Yuval Ramot
1
,
Krassimira Nanova
2
,
Sofia-Maria Faitatziadou
1
,
Dania Abu Assab
1
,
Yackov Berkun
3
,
Abraham Zlotogorski
1
Affiliations
1
Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
2
Clalit Health Services, Jerusalem, Israel.
3
Department of Pediatrics, Hadassah Mount Scopus Medical Center, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
PMID:
35971582
PMCID:
PMC9539206
DOI:
10.1111/ddg.14784_g
No abstract available
Publication types
Letter